Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522559/0/en/Surgalign-Launches-Portfolio-of-Fortilink-with-TiPlus-Technology-Products-Expanding-its-Addressable-Market-for-Interbody-Fusion-Procedures.html

DEERFIELD, Ill., Sept. 26, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the expansion of its Fortilink product portfolio with the introduction and commercial launch of a new family of interbody fusion devices featuring TiPlus technology.

Read more at globenewswire.com

Related news for (SRGA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.